#health policy

Même sans tous les détails de l’extrait fourni, le message est clair : les traitements psychédéliques se sont rapprochés du centre du débat sur la politique de santé aux États-Unis.

Le CMS a indéfiniment retardé un programme pilote de Medicare consacré à la couverture des médicaments contre l’obésité, après que les régimes d’assurance ont indiqué qu’ils n’étaient pas prêts à participer.

Un nouveau rapport indique que les hommes âgés bénéficiant d’une aide fédérale au logement au moment du diagnostic d’un cancer de la prostate avaient une meilleure survie à deux ans que des patients comparables sans ce soutien.

De nouvelles recherches indiquent que la réduction de la charge administrative dans les demandes d’aides peut augmenter les taux de demande et d’inscription au WIC.

Une nouvelle impulsion fédérale visant à accélérer l’accès aux traitements psychédéliques et à réexaminer leur statut de substances contrôlées signale un changement de politique majeur dans l’approche de Washington face aux thérapies de santé mentale.

Lors d'une audience à la Chambre, le secrétaire à la Santé et aux Services sociaux Robert F. Kennedy Jr. a défendu la FDA et le commissaire Marty Makary, présentant Makary comme un responsable soumis à une forte pression de l'industrie pharmaceutique, alors que des républicains soulevaient leurs

La FDA se rapproche de la nomination d’un nouveau directeur pour son Center for Biologics Evaluation and Research, selon Endpoints News, une décision aux implications importantes pour les vaccins et la réglementation des produits biologiques.

A new Medical Xpress report says the pandemic-era federal requirement to keep Medicaid beneficiaries enrolled extended postpartum coverage nationwide and significantly increased enrollment.

AbbVie has sued the federal government over how it interprets the word “patient” in the 340B drug discount program, opening a new front in one of the most consequential pricing disputes in U.S. healthcare.

Steve Ubl, the longtime head of drug industry lobbying group PhRMA, is set to leave the CEO role at the end of 2026, marking a major leadership change for one of Washington’s most influential healthcare trade groups.

Pharmaceutical companies and patient groups are pushing to exempt orphan drugs from potential Colorado pricing limits, opening a new front in the broader debate over rare-disease treatments and affordability.

A STAT item indicates that a major Medicare Advantage announcement due April 6 could show how the Trump administration intends to work with private Medicare insurers.

An opinion essay on mitochondrial disease argues that medical nutrition is essential to keeping some patients healthy, yet insurers still often treat it as optional rather than medically necessary.

The White House’s 2027 budget request proposes a major cut to federal health agencies, including a $5 billion reduction for the NIH and a plan to shrink its institute structure.

A new cross-sectional study suggests that extending Medicaid work requirements nationwide could place roughly half of adult beneficiaries at risk of losing coverage, despite many already facing significant barriers to

A major review in Nature Medicine argues that physical activity must be repositioned from a lifestyle recommendation to a foundational public health intervention, with implications for how health systems are designed and funded.

The CDC has had a Senate-confirmed director for just 28 days during the current administration, even as Congress passes its first bipartisan health care legislation in over three years. A look at the leadership vacuum, policy progress, and regulatory flashpoints shaping Washington health policy.

MIT Technology Review's daily briefing features an exclusive interview with US Deputy Health Secretary Jim O'Neill on longevity science and vaccine policy, plus the surprising truth about why real heists are nothing like the movies.

A comprehensive review of over 80 peer-reviewed studies finds that contracting out health care can improve access in remote areas, but only when governments maintain strong oversight and communities have a real say in how services are run.